A Montana based molecular diagnostic company, Alercell Inc., is pioneering novel techniques to augment the way leukemia is diagnosed, treated and ultimately prevented.
/PRNewswire/ ALERCELL, INC. announced today that it has introduced a molecular Leukemia diagnostic platform. LENA Molecular Dx Leukemia Platform is a core.
The Global HPV testing and Pap Test Market was valued at US$ 2.2 Bn in 2021 and is expected to reach US$ 15 Bn by 2032, finds Future Market Insights (FMI) in a recent market survey. As per the findings of the report, Pap Testing will remain pivotal for the market as the bulk of revenue will be generated through this.
/PRNewswire/ Alercell today announced the opening of Alercell UK LTD. with principal office in central London (UK). Alercell will develop in London its R&D.